{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:23:01Z","timestamp":1768011781870,"version":"3.49.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Taiwan University Hospital Yun-Lin Branch","award":["NTUHYL104.I004"],"award-info":[{"award-number":["NTUHYL104.I004"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182344","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T13:26:11Z","timestamp":1501593971000},"page":"e0182344","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2101-0887","authenticated-orcid":true,"given":"Ting-Syuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ying","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Lun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Min","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoh-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko-Jen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenh-Chen","family":"Hsein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Chou","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48","author":"JA G\u00f3mez-Puerta","year":"2014","journal-title":"Journal of autoimmunity"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood-2007-12-129627","article-title":"How we diagnose the antiphospholipid syndrome","volume":"113","author":"B Giannakopoulos","year":"2009","journal-title":"Blood"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrrheum.2014.39","article-title":"Therapy: Antiphospholipid syndrome research needs more collaboration","volume":"10","author":"D Erkan","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11926-007-0004-3","article-title":"Neurologic manifestations of the antiphospholipid syndrome","volume":"9","author":"JF Roldan","year":"2007","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0961203310396748","article-title":"Antiphospholipid antibodies and the brain: a consensus report","volume":"20","author":"RL Brey","year":"2011","journal-title":"Lupus"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1191\/0961203303lu392oa","article-title":"Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies","volume":"12","author":"J Chapman","year":"2003","journal-title":"Lupus"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/rheumatology\/keg080","article-title":"Central nervous system involvement in the antiphospholipid (Hughes) syndrome","volume":"42","author":"G Sanna","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11926-001-0034-1","article-title":"Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome","volume":"3","author":"M Rovaris","year":"2001","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"ref10","first-page":"17","article-title":"Technetium-99mTc-HMPAO brain SPECT in antiphospholipid syndrome\u2014preliminary data","volume":"3","author":"G Romanowicz","year":"2000","journal-title":"Nuclear Medicine Review"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00296-003-0314-3","article-title":"Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement\u2014a preliminary report","volume":"23","author":"S Sun","year":"2003","journal-title":"Rheumatology international"},{"key":"ref12","first-page":"350","article-title":"Nuclear medicine: the requisites","author":"HA Ziessman","year":"2013"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1109\/TNS.1978.4329385","article-title":"A method for attenuation correction in radionuclide computed tomography","volume":"25","author":"L-T Chang","year":"1978","journal-title":"IEEE Transactions on Nuclear Science"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/art.37759","article-title":"A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome","volume":"65","author":"D Erkan","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrrheum.2015.88","article-title":"Current treatment of antiphospholipid syndrome: lights and shadows","volume":"11","author":"G Espinosa","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"ref16","first-page":"34","article-title":"Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients","volume":"32","author":"E Kozora","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"RT Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.2010.142042","article-title":"Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study","volume":"70","author":"A Ruffatti","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","article-title":"GAPSS: the Global Anti-Phospholipid Syndrome Score","volume":"52","author":"S Sciascia","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1177\/0961203314537361","article-title":"Antiphospholipid scoring: significance in diagnosis and prognosis","volume":"23","author":"K Oku","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"PL Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"25","key":"ref22","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1182\/blood-2011-04-346734","article-title":"A new fish for the \u03b22GPI hook: LPS!","volume":"117","author":"JH Rand","year":"2011","journal-title":"Blood"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"B Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MOH.0b013e3283497f3e","article-title":"Complement and the antiphospholipid syndrome","volume":"18","author":"W Lim","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"V Pengo","year":"2011","journal-title":"Blood"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2967\/jnumed.115.163469","article-title":"Tumor texture analysis in PET: where do we stand?","volume":"56","author":"I Buvat","year":"2015","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"e110300","DOI":"10.1371\/journal.pone.0110300","article-title":"Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review","volume":"9","author":"L Alic","year":"2014","journal-title":"PloS one"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/RLU.0000000000000867","article-title":"Prognostic Significance of Intratumoral Metabolic Heterogeneity on 18F-FDG PET\/CT in Pathological N0 Non\u2014Small Cell Lung Cancer","volume":"40","author":"D-H Kim","year":"2015","journal-title":"Clinical nuclear medicine"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0925-4927(01)00130-5","article-title":"Changes in brain functional homogeneity in subjects with Alzheimer's disease","volume":"114","author":"ND Volkow","year":"2002","journal-title":"Psychiatry Res"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.mnm.0000194399.04820.31","article-title":"Cerebral perfusion heterogeneity and complexity in patients with acute subarachnoid haemorrhage","volume":"27","author":"T Mustonen","year":"2006","journal-title":"Nucl Med Commun"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/jnnp.2007.142851","article-title":"Heterogeneity of cerebral perfusion 1 week after haemorrhage is an independent predictor of clinical outcome in patients with aneurysmal subarachnoid haemorrhage","volume":"79","author":"T Mustonen","year":"2008","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2191-219X-2-40","article-title":"Comparison of heterogeneity quantification algorithms for brain SPECT perfusion images","volume":"2","author":"R Modzelewski","year":"2012","journal-title":"EJNMMI Res"},{"issue":"9","key":"ref33","first-page":"1939","article-title":"The spectrum of the antiphospholipid syndrome: a matter of perspective","volume":"28","author":"CA Clark","year":"2001","journal-title":"J Rheumatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:40:18Z","timestamp":1540035618000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182344"}},"subtitle":[],"editor":[{"given":"Christophe","family":"Leroyer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182344","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}